Background: The World Health Organization (WHO) declared the pandemic disease caused by SARS-CoV-2 as coronavirus disease 2019 (COVID-19). Presently, COVID-19 has infected individuals in over seventy nations across the world. China had a significant COVID-19 impact and taken great measures to restrict the disease's development and increase the cure rate. Objective: Research paper describes the clinico-epidemiological profile of SARS-CoV-2 infection in individuals tested at state key Virology Research and Diagnostic Laboratory (VRDL), Pt. J.N.M. Medical College, Raipur (CG), India. Method: Respiratory samples oropharyngeal and nasopharyngeal swabs were collected in VTM from suspected COVID-19 individuals for laboratory analysis and cases were confirmed by reverse transcription polymerase chain reaction (RT-PCR). A total of 32,145 patients with confirmed diagnosis of SARS-CoV-2 infection were included in this study. Data included in this study, from the period of August 2020 to February 2021, were collected from offline and online medical records. Result: Amongst 32,145 SARS-CoV-2 infected patients, 19674 (61%) were males and 12471 (39%) were females, 5756 (17.90%) were symptomatic and 26,389 (82.10%) were asymptomatic. Maximum percentage of symptomatic subjects were found in 70-79 years (25%) followed by 60-69 years (24%), out of 5756 symptomatic patients 3772 (65.53%) were males and 1984 (34.46%) were females, most common presenting symptom was cough (80.9%) followed by fever (33.8%), sore throat (16.1%) breathlessness (14.1%). The most common comorbidity found among symptomatic group was hypertension followed by diabetes. Conclusion: COVID-19 is an evolving disease and data from our study help in understanding the clinic-epidemiological profile of patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.